SLE classification criteria: Is "The causality principle" integrated and operative - and do the molecular and genetical network, on which criteria depend on, support the definition of SLE as "a one disease entity" - A theoretical discussion

被引:3
作者
Rekvig, Ole Petter [1 ,2 ]
机构
[1] Furst Med Lab, Oslo, Norway
[2] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Tromso, Norway
关键词
Chromatin autoimmunity; Systemic lupus erythematosus; Lupus nephritis; Endonucleases; DNase; 1; The causality principle; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTINUCLEAR ANTIBODIES; REVISED CRITERIA; DNA ANTIBODIES; HEAVY-CHAIN; ANTI-DSDNA; NEPHRITIS; MURINE; AUTOANTIBODY; NUCLEOSOMES;
D O I
10.1016/j.autrev.2023.103470
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Molecular and cellular aspects of the autoimmune pathophysiology in SLE is linked to the "The causality principle". SLE Classification Criteria identify per definition disease measures (here: synonymous with classification criteria), but not diagnostic criteria within a classical framework. These two mostly theoretical criteria collections represent a salient conflict between phenomenology and the causality principle - between disease measures and molecular interactions that promote such measures, in other words their cause(s). Essentially, each criterion evolves from immunogenic and inflammatory signals - some are interconnected, some are not. Disparate signals instigated by disparate causes. These may promote clinically heterogenous SLE cohorts with respect to organ affection, autoimmunity, and disease course. There is today no concise measures or arguments that settle whether SLE cohorts evolve from one decisive etiological factor (homogenous cohorts), or if disparate pathobiological factors promote SLE (heterogenous cohorts). Current SLE cohorts are not ideal substrates to serve as study objects if the research aims are to describe etiology, and molecular interactions that cause - and link primary and secondary pathophysiological events together - events that account for early and progressive SLE. We have to develop SLE criteria allowing us to identify definable categories of SLE in order to describe etiology, pathophysiology and diagnostic criteria of delimitated SLE versions. In this regard, the causality principle is central to define dominant etiologies of individual SLE categories, and subsequent and consequent down-stream diagnostic disease measures. In this sense, we may whether we like it or not identify different SLE categories like "genuine SLE" and "SLE-like non-SLE" syndromes. Many aspects of this problem are thoroughly discussed in this study.
引用
收藏
页数:11
相关论文
共 111 条
  • [1] Systemic lupus erythematosus one disease or many?
    Agmon-Levin, N.
    Mosca, M.
    Petri, M.
    Shoenfeld, Y.
    [J]. AUTOIMMUNITY REVIEWS, 2012, 11 (08) : 593 - 595
  • [2] Whole-genome sequencing identifies complex contributions to genetic risk by variants in genes causing monogenic systemic lupus erythematosus
    Almlof, Jonas Carlsson
    Nystedt, Sara
    Leonard, Dag
    Eloranta, Maija-Leena
    Grosso, Giorgia
    Sjowall, Christopher
    Bengtsson, Anders A.
    Jonsen, Andreas
    Gunnarsson, Iva
    Svenungsson, Elisabet
    Ronnblom, Lars
    Sandling, Johanna K.
    Syvanen, Ann-Christine
    [J]. HUMAN GENETICS, 2019, 138 (02) : 141 - 150
  • [3] Monogenic Lupus: A Developing Paradigm of Disease
    Alperin, Jessie M.
    Ortiz-Fernandez, Lourdes
    Sawalha, Amr H.
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [4] Antinuclear antibodies (ANA) as a criterion for classification and diagnosis of systemic autoimmune diseases
    Andrade, Luis Eduardo C.
    Damoiseaux, Jan
    Vergani, Diego
    Fritzler, Marvin J.
    [J]. JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2022, 5
  • [5] [Anonymous], 2018, The international encyclopedia of biological anthropology, DOI [10.1002/9781118584538, DOI 10.1002/9781118584538]
  • [6] Assessing the EULAR/ACR classification criteria for patients with systemic lupus erythematosus
    Aringer, Martin
    Costenbader, Karen
    Johnson, Sindhu R.
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (02) : 135 - 144
  • [7] Systemic Lupus Erythematosus Classification and Diagnosis
    Aringer, Martin
    Johnson, Sindhu R.
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2021, 47 (03) : 501 - 511
  • [8] Classifying and diagnosing systemic lupus erythematosus in the 21st century
    Aringer, Martin
    Johnson, Sindhu R.
    [J]. RHEUMATOLOGY, 2020, 59 : 4 - 11
  • [9] Aringer M, 2019, ARTHRITIS RHEUMATOL, V71, P1400, DOI [10.1002/art.40930, 10.1136/annrheumdis-2018-214819]
  • [10] Kidney biopsy teaching case SLE: The great imitator strikes again
    Bell, JM
    Nair, R
    Solon, A
    Walker, PD
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (01) : 219 - 222